Jefferies Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-100,000
Closed -$446K 2127
2021
Q3
$446K Buy
+100,000
New +$482K ﹤0.01% 1268
2021
Q1
Sell
-426
Closed -$2.04K 2105
2020
Q4
$2.04K Sell
426
-7,906
-95% -$40K ﹤0.01% 1528
2020
Q3
$49K Buy
8,332
+1,618
+24% +$9.68K ﹤0.01% 1285
2020
Q2
$45 Sell
6,714
-6,332
-49% -$47.9K ﹤0.01% 1159
2020
Q1
$83K Sell
13,046
-6,188
-32% -$49.6K ﹤0.01% 1817
2019
Q4
$201K Sell
19,234
-178,373
-90% -$1.3M ﹤0.01% 2256
2019
Q3
$777K Buy
197,607
+175,064
+777% +$1.42M 0.01% 1646
2019
Q2
$335K Buy
22,543
+6,543
+41% +$118K ﹤0.01% 1870
2019
Q1
$397K Sell
16,000
-26,426
-62% -$662K ﹤0.01% 1691
2018
Q4
$762K Sell
42,426
-2,167
-5% -$44.3K 0.01% 1293
2018
Q3
$1.31M Buy
44,593
+13,200
+42% +$511K 0.01% 1189
2018
Q2
$1.43M Buy
+31,393
New +$1.53M 0.01% 1067
2018
Q1
Sell
-2,937
Closed -$200K 2841
2017
Q4
$200K Sell
2,937
-22,063
-88% -$1.54M ﹤0.01% 2222
2017
Q3
$2.06M Buy
+25,000
New +$1.98M 0.01% 934
2017
Q2
Sell
-35,000
Closed -$2.14M 2680
2017
Q1
$2.23M Buy
35,000
+32,900
+1,567% +$2M 0.02% 850
2016
Q4
$93K Sell
2,100
-15,500
-88% -$546K ﹤0.01% 2026
2016
Q3
$634K Sell
17,600
-5,512
-24% -$118K ﹤0.01% 1508
2016
Q2
$317K Buy
+23,112
New +$338K ﹤0.01% 1643
2016
Q1
Sell
-15,100
Closed -$320K 2664
2015
Q4
$529K Buy
+15,100
New +$974K ﹤0.01% 1513
2015
Q3
Sell
-225
Closed -$19.5K 3250
2015
Q2
$20K Buy
225
+200
+800% +$17.1K ﹤0.01% 2621
2015
Q1
$2K Buy
+25
New +$1.76K ﹤0.01% 2020
2014
Q4
Sell
-28
Closed -$1K 2444
2014
Q3
$1K Buy
+28
New +$1.17K ﹤0.01% 2098
2014
Q2
Sell
-34,541
Closed -$1.78M 2463
2014
Q1
$2.39M Buy
+34,541
New +$2.54M 0.02% 548
2013
Q4
Sell
-23,098
Closed -$1.4M 2290
2013
Q3
$1.4M Buy
+23,098
New +$1.64M 0.01% 758

Other funds holding CLVS